Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. ascopubs.org › doi › 10Systemic Treatment of Patients With Metastatic Breast Cancer:...

   ascopubs.org › doi › 10

   10 Ιαν 2024 · The purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings.

2. ascopubs.org › jco › specialASCO Clinical Practice Guidelines | Journal of Clinical Oncology

   ascopubs.org › jco › special

   Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline January 28, 2021. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update October 20, 2020

3. society.asco.org › practice-patients › guidelinesBreast Cancer - ASCO

   society.asco.org › practice-patients › guidelines

   • Αποθηκευμένο αντίγραφο

   Systemic Treatment of Patients With Metastatic Breast Cancer Resource–Stratified Guideline January 10, 2024 Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

4. pubmed.ncbi.nlm.nih.gov › 38206277Systemic Treatment of Patients With Metastatic Breast Cancer:...

   pubmed.ncbi.nlm.nih.gov › 38206277

   Abstract. Purpose: To guide clinicians and policymakers in three global resource-constrained settings on treating patients with metastatic breast cancer (MBC) when Maximal setting-guideline recommended treatment is unavailable.

5. ascopost.com › issues › may-25-2022ASCO Guideline Rapid Update Addresses the Use of ... - ASCO Post

   ascopost.com › issues › may-25-2022

   • Αποθηκευμένο αντίγραφο

   25 Μαΐ 2022 · In the 2022 ASCO Guideline update, pembrolizumab at 200 mg every 3 weeks or 400 mg every 6 weeks is recommended in combination with neoadjuvant chemotherapy, followed by adjuvant pembrolizumab after surgery, for patients with T1cN1–2 to T2–4N0 (stage II/III) early-stage triple-negative breast cancer.1 Adjuvant pembrolizumab may be given concurre...

6. acsjournals.onlinelibrary.wiley.com › doi › 10Updated ASCO guidelines for patients with HER2-positive breast...

   acsjournals.onlinelibrary.wiley.com › doi › 10

   12 Δεκ 2022 · The American Society of Clinical Oncology recently published two updated guidelines on issues related to the diagnosis and treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer.

7. www.asco.org › sites › new-wwwNeoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy...

   www.asco.org › sites › new-www

   The ASCO Clinical Practice Guidelines Committee guideline process includes: a systematic literature review by ASCO guidelines staff. an expert panel provides critical review and evidence interpretation to inform guideline recommendations. final guideline approval by ASCO CPGC.